来源: MarketWatch ↗
Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.
|
暂时无法翻译，请重试。
来源报道重点
As part of the agreement, Hims said it won’t compound GLP-1 medications like Zepbound in the future.
在 MarketWatch 阅读原始报道 ↗